Abstract
Purpose
Globally adults are not consuming enough fibre. One barrier to higher fibre intake may be the experience or expectation of gastrointestinal (GI) symptoms including flatulence, bloating and abdominal pain. Identifying experiences of GI symptoms and perceptions of the role foods play could inform dietary advice to increase fibre consumption.
Methods
An online questionnaire explored GI symptoms in UK adults and their perceived association with individual foods (vegetables, fruit, fibre-rich products and other commonly consumed foods/drinks).
Results
Of 516 respondents (85% female, median age 38 years), 72.1% reported no existing GI conditions, yet 86% experienced GI symptoms in the past month (flatulence (72%), bloating (64%) and abdominal rumbling (58%)). The most concerning (causing anxiety or worry) symptoms were bloating (18%), heartburn (16%) and abdominal pain (13%). Among those without declared GI conditions, 71% attributed symptoms to foods/drinks, with 42% avoiding specific items, notably dairy (17%) and vegetables (13%). Food avoidance was more common in respondents with IBS (78%, P < 0.05). The most common perceptions were that beans (34%) and Brussels sprouts (23%) cause flatulence, fatty and dairy foods cause bloating (17%) and carbonated soft drinks cause belching (17%).
Conclusions
Although flatulence was attributed to some fermentable fibre-rich foods, this symptom did not worry most respondents. The most concerning symptoms (bloating, pain and heartburn) were more commonly associated with other food categories (fatty, dairy and spicy foods). Reassurance that higher fibre intakes are unlikely to cause worrying symptoms could be important in dietary advice to increase consumption.
Keywords: Gastrointestinal symptoms, Dietary fibre, UK adults, Diet
Introduction
Dietary fibre intake in the UK, and in many other countries, is well below recommendations in all age groups, despite continued public health efforts to promote the well-established health benefits [1–3]. In the UK, adults are advised to consume at least 30g fibre per day, however, 91% of the population do not meet this recommendation [4, 5]. Barriers associated with increasing fibre consumption are complex and may be linked to both socio-demographic and modifiable factors such as pre-existing knowledge and beliefs. These include hedonic preferences, resistance to behaviour change, perceived cost and preparation barriers, poor knowledge of the beneficial health impacts of fibre and potential links with gastrointestinal (GI) symptoms [6, 7].
Foods containing low molecular weight dietary fibres (e.g. oligosaccharides and inulin), can have an osmotic effect in the small intestine which in larger quantities may cause abdominal discomfort, rapid delivery of undigested intestinal contents to the large bowel and loose stool [8]. Other dietary components that can also exert osmotic effects in the gut include lactose (found in milk and other dairy products) [9] and polyols (found naturally in certain fruits and vegetables but also used in high amounts as sugar-free sweeteners in foods such as confectionery) [10].
Microbial fermentation of fibre with substantial gas production may be the source of symptoms for some people including abdominal discomfort, bloating, distension and flatulence [11]. Fibre-rich foods which may be associated with increased gas production include legumes, pulses, cruciferous vegetables, onions and garlic, however, dairy products and wheat fibre can have a similar effect [8]. Symptoms following increased consumption of poorly digested carbohydrates may also stem from more solid contents in the colon distending the lumen, a feeling to which some individuals may not be accustomed. Colomier et al. explored the prevalence and burden of self-reported meal-related abdominal pain in a large-scale study of healthy participants (n = 54,127) in 26 countries, including the UK, USA and Australia [12]. In this study 33.8% of participants reported experiencing meal-related abdominal pain, with 11% reporting frequent meal-related abdominal pain (defined as more than 50% of total abdominal pain episodes related to meals). Those experiencing frequent meal-related abdominal pain also reported experiencing a lower physical and mental quality of life compared to those with occasional or no meal-related abdominal pain. This study demonstrates the widespread nature of these experiences and highlights the need to explore which meal components may have the greatest impact. Although participants were recruited on the assumption that they were healthy, 25% of those reporting frequent meal related pain met the Rome IV criteria for irritable bowel syndrome (IBS) based on their symptom reports.
The impact of increased intestinal gas or fluid on the experience of GI symptoms may vary widely and depend on individual perceptions and visceral sensitivity [13]. Individuals with IBS report increased symptoms compared to healthy individuals despite the absence of identifiable structural abnormalities or any considerable difference in intestinal gas production [14–20]. Although the aetiology of IBS is not clear, it is thought that increased visceral sensitivity, altered gut motility, impaired gas handling, carbohydrate malabsorption, the gut microbiota, immune system and gut brain axis all contribute to symptom generation [21].
Expectations of ‘normal’ symptoms may also influence individual tolerance levels. Nationally representative surveys suggest that between 38–61% of Western populations report GI symptoms on a regular basis [22–25]. The most reported symptoms in large scale nationally representative studies in American and European adults were flatulence, heartburn/reflux, bloating, abdominal rumbling/borborygmi, constipation and diarrhoea [23, 24]. An individual’s perceptions of dietary causes of GI symptoms may influence future dietary choices, which could be a concern if excluded foods are fibre-rich [26]. Avoidance of foods associated with GI symptoms has been reported in individuals with IBS and is associated with reduced quality of life, reduced energy, protein, carbohydrate [27] and micronutrient intake [28] and altered microbiome composition [29]. Dietary changes or complete avoidance of foods perceived to cause symptoms were reported by 92% of individuals with IBS compared to 46% of healthy individuals in a study carried out in Ireland (n = 135 IBS and n = 111 healthy participants) [30]. The foods most perceived to cause or worsen GI symptoms in healthy individuals and those with IBS were cereal-based foods (e.g. bread, wheat, pasta and breakfast cereal, spicy foods and vegetables). It is important to explore perceptions of foods particularly those beneficial for health including fibre-rich foods, in relation to GI symptoms, in healthy individuals and in those more likely to experience symptoms (e.g. those with IBS). Adherence to dietary fibre intake recommendations is poor in many countries. Better understanding of potential barriers to fibre consumption may help develop strategies to promote sustained increased intakes.
Therefore, the aim of this study was to explore current experiences of GI symptoms in the general UK population, the perceived effect of foods and factors which may influence this.
Methods
Study design
This cross-sectional survey of the UK adult population (aged 18y +) was conducted between September 2020 and February 2021. A minimum sample size of 384 was required based on Cochran’s sample size estimation for studies of large populations where variation of an outcome is not clear [31]. The estimated size of the population of interest (UK adult (aged 18 + years) population) is approximately 55,500,000 [32]. The sample size formula for categorical data described by Cochran was deemed most appropriate within the context of this study [33]. The alpha level a priori was set at 0.05, acceptable margin of error at 5% and, although the standard deviation of the outcomes were not known, an estimated variance of 0.5 was used.
Participants were recruited via social media sites including Facebook, Twitter, LinkedIn, Reddit, forums and via word of mouth. Participants accessed the online survey and study information via a web link. After reading the study information, participants could decide not to take part by closing the web page or they could continue, give their consent for the study electronically and complete the survey.
Questionnaire
The 8-part, 43 question survey was developed using an online tool (JISC Online Surveys, Bristol) following a review of the literature relating to the assessment of GI symptoms in a clinical research context [25, 34–40]. Information regarding participant demographics, digestive symptoms, impact of symptoms and associations between diet and symptoms was collected (Table 1). After piloting with eight individuals, the questionnaire was shortened and more detail added to the participant information sheet regarding the length of the survey and approximate time required to complete it.
Table 1.
Summary of content of GI symptom survey questionnaire
| Section | Content |
|---|---|
| 1. Demographics | Age, sex, education level, length of residence in UK, diet type, GI conditions, medication, smoking, alcohol |
| 2. GI symptoms | Experience of GI symptoms in past 4 weeks, bowel movements, most common and most concerning symptoms |
| 3. Impact of GI symptoms | Diet, lifestyle, body image, sleep, visceral sensitivity index |
| 4. Perceived causes of GI symptoms | Foods/drinks and avoidance |
| 5. Food choices and GI symptoms | Impact of perceived dietary causes of GI symptoms on food/drink choices |
| 6. Diet | Frequency of consumption of fruit, vegetables, wholegrains, beans and pulses, nuts and seeds |
| 7. Physical activity | IPAQ—International physical activity questionnairea |
| 8. Personality | TIPI – Ten item personality indexb, Obsessive beliefs and behavioursc |
GI symptom scoring
Categorical ordinal response data relating to symptom frequency and severity were used to create a numerical score for each symptom and an overall symptom score for each respondent. Each frequency category was assigned a numerical value: Monthly = 1, 2–3 times a month = 2, Weekly = 3, 2–6 times a week = 4, Daily = 5, More than once a day = 6. Each severity category was also assigned a numerical value: Mild = 1, Moderate = 2, Severe = 3. For each symptom report the frequency numerical value was multiplied by the severity numerical value to create a score for each symptom. The total symptom score for each participant was the sum of the individual symptom scores. The maximum possible symptom score was 162 (maximum score for each individual symptom was 18 (6 × 3) and there were nine possible symptoms to report).
Foods/drinks and GI symptoms
A list of 32 foods and drinks, including some that have previously been reported in the literature as potential causes of GI symptoms, were included in the questionnaire [43–45]. Foods and drinks were chosen to represent foods which may commonly be associated with GI symptoms (e.g. beans), but also foods which may be less commonly associated with symptoms (e.g. low sugar/fat food and sweets—normal or sugar-free). Respondents could also report additional foods that induce symptoms not included in the list. Respondents were asked whether they associate any of the foods or drinks specifically with any of the following symptoms: flatulence, abdominal bloating, rumbling/borborygmi, abdominal pain, constipation, diarrhoea, heartburn, belching or nausea.
GI medications
Respondents were asked whether they consumed anti-reflux, antacids or heartburn medication (e.g. Gaviscon, Rennie’s, aluminium hydroxide, magnesium carbonate or proton pump inhibitors (omeprazole, lansoprazole etc.)) and, if so, how often they consumed these.
Data analysis and statistics
All statistical analysis and data handling was conducted using IBM SPSS Statistics version 28.0 and Microsoft Excel version 16.62. Normally distributed numerical data are presented as mean (standard deviation (SD)) and non-normally distributed data as median (interquartile range (IQR)). Categorical data are presented as counts and % of total/group where appropriate. The survey was set up so that a response was mandatory for most questions to allow submission, eliminating the potential for missing data in complete submissions. Non-response to any free text non-mandatory survey questions was not considered missing data, as these items were optional for respondents. As such, the analysis was conducted using available data for each question, without the need for exclusion due to non-response. Binary or categorical data were analysed using chi squared tests. The purpose of this analysis was to test for associations between certain demographic factors (sex, GI medication use) and experience of symptoms and perceptions of the GI impact of foods. Numerical data were analysed by t test and one way ANOVA if data were normally distributed, and Mann Whitney U tests or Kruskal Wallis if data were not normally distributed. This was to assess differences in GI symptom scores between groups. A P value < 0.05 was considered significant. Association of personality traits and symptoms were assessed by correlation of scores.
Ethics
Ethical approval for the study was granted by the University of Glasgow, College of Medical Veterinary and Life Sciences Ethics Committee (approval number: 200190172 granted on 29.07.20).
Results
The median age of the 516 respondents was 38 years (IQR 22), 85% were female and 15% male (Table 2). Nearly all respondents stated that they had lived in the UK for more than 5 years (96%). The education level of the respondents was high, with 77% stating they have obtained a university degree (undergraduate programme (37%) or a postgraduate programme (40%)). Most respondents stated they had no conditions affecting bowel/intestinal health (72.1%). However, 100 (19%) respondents self-reported having IBS and 44 (9%) that they have another bowel/intestinal condition (self-reported food intolerance/allergy, n = 14; inflammatory bowel disease n = 8; acid reflux n = 6; coeliac disease n = 5; surgical procedure n = 4; diverticular disease n = 3; other condition n = 4). The original intention of this study was not to compare experiences of individuals with no existing GI conditions to those with IBS, however, given the large proportion of individuals with IBS who completed the survey this additional analysis was carried out. The 44 respondents with GI conditions other than IBS were not included in statistical analysis due to the heterogeneity and low number of this group. Only descriptive statistics for these respondents are presented within the results sections referring to all respondents.
Table 2.
Demographics of respondents to the GI symptom survey
| Characteristic | n | % |
|---|---|---|
| Number of respondents | 516 | 100 |
| Sex | ||
| Females | 438 | 84.9 |
| Males | 77 | 14.9 |
| Other | 1 | 0.2 |
| UK residence | ||
| Lived in UK for > 5 years | 496 | 96.1 |
| Diet type* | ||
| Typical UK diet | 260 | 50.4 |
| Mixture of typical UK food and that of other cultures | 246 | 47.7 |
| Food traditional to ethnic group | 10 | 1.9 |
| Education level | ||
| Schooling completed at 16y | 35 | 6.8 |
| Schooling completed at 17-18y | 77 | 14.9 |
| Undergraduate programme | 191 | 37 |
| Postgraduate programme | 207 | 40.1 |
| GI health | ||
| No diagnosis of any conditions affecting bowel/intestinal health | 372 | 72.1 |
| IBS (self-reported) | 100 | 19.4 |
| Other bowel/intestinal conditions (self-reported) | 44 | 8.5 |
| Fibre-rich food consumption | ||
| Considers their own diet to be high in fibre | 171 | 33.1 |
| Eats ≥ 5 portions of fruit and vegetables/day | 256 | 49.6 |
| Smoking and alcohol | ||
| Cigarette smokers | 28 | 5.4 |
| Alcohol drinkers | 403 | 78.1 |
| Consume < 1–13 units of alcohol/week | 367 | 71.1 |
| Consume ≥ 14 units of alcohol/week | 36 | 7.0 |
*No additional information regarding what constituted each diet type was given
General experiences of GI symptoms
Eighty six percent of all respondents reported experiencing at least one GI symptom in the previous 4 weeks. For 91% this was their normal experience and 58% felt that symptoms negatively impact their life. Of those who experienced symptoms, 41% experienced at least one symptom daily and 38% experienced at least one symptom more than once a day. Flatulence was the symptom most commonly experienced more than once a day (31%). The most commonly reported symptom was flatulence (72%) followed by bloating (64%), abdominal rumbling (58%) and abdominal pain (57%). The most concerning symptoms for all respondents were bloating (18%), pain (16%) then diarrhoea (13%).
Symptoms were reported by 81% of those with no GI conditions and 99% of those with IBS. Reports of individual symptoms and symptoms which elicited concern in those with no GI conditions are shown in Fig. 1. For those with IBS, flatulence (87%), bloating (85%), abdominal pain (85%) and abdominal rumbling (80%) were the most commonly reported symptoms. For those with IBS the most concerning symptom was pain (26%) followed by bloating (21%), diarrhoea (21%) and flatulence (20%). In relation to symptom scoring, both individual symptom and total symptom scores were generally low. For all respondents, the median total symptom score was 24 (IQR: 34.6) and the highest symptom score was for flatulence (5 (12)) followed by bloating (3 (9.3)) and then rumbling (2 (6)). The highest possible score was 162.
Fig. 1.
Total symptom reports and most concerning symptom reports for survey respondents with no GI conditions (n = 372)
Food/drinks and GI symptoms
Seventy six percent of respondents reported that specific foods/drinks cause them to experience GI symptoms. Respondents were then asked whether they avoid any foods/drinks that induce symptoms and 52% said that they did. A smaller proportion of those with no GI conditions felt that foods/drinks induce symptoms (no GI conditions: 71%, IBS: 88%) and routinely avoid certain foods/drinks (no GI conditions: 42%, IBS: 78%) compared to those with IBS (P < 0.05).
Perceptions of the contribution of foods and drinks to GI symptoms
Thirty two percent of respondents with no GI conditions reported that beans cause flatulence, 22% felt Brussels sprouts cause flatulence, 17% that carbonated drinks cause belching and 15% and 12% felt that fatty and dairy foods cause bloating respectively. Spicy foods were reported as causing heartburn and diarrhoea in 15% and 14% of respondents respectively and 12% felt that fatty foods cause abdominal pain. The 12 foods/drink categories most commonly associated with digestive symptoms (≥ 10% of total respondents reported) are shown in Fig. 2. A greater proportion of those with IBS reported that beans cause flatulence (41%), spicy foods cause flatulence (25%), fatty foods cause pain (29%) and cheese/yoghurt cause bloating (28%) compared to those with no GI conditions (P < 0.05).
Fig. 2.
Reports of specific symptoms caused by foods/drinks in survey respondents (N = 372) with no GI conditions. Bsprouts = Brussels sprouts, WM/WG = wholemeal or wholegrain bread, Fatty =—fatty foods, Alcohol = any alcoholic drinks, Soft D (c) = Carbonated soft drinks, Spicy = Any spicy food
Avoidance of foods
Avoidance of foods/drinks due to perceived symptoms was reported by 52% of respondents. This included 42% of those with no GI conditions and 78% with IBS (P < 0.001). For nearly all food/drink categories respondents reported avoiding, a greater proportion of those with IBS avoided these compared to respondents with no GI conditions (Table 3).
Table 3.
Food categories avoided by respondents with no GI conditions and IBS due to GI symptoms
| Food/drink category | No GI conditions n (% of respondents) | IBS n (% of respondents) |
|---|---|---|
| Number of respondents | 372 (100) | 100 (100) |
| Dairy products | 63 (17) | 44 (44) |
| Vegetables | 49 (13) | 54 (54) |
| Drinks | 43 (12) | 28 (28) |
| Fizzy drinks | 24 (6) | 7 (7) |
| Alcohol | 13 (3) | 11 (11) |
| Hot caffeinated drinks | 4 (1) | 10 (10) |
| Fruit juice | 2 (0.5) | 0 (0) |
| Processed/refined carbohydrates | 45 (12) | 19 (19) |
| Spicy foods | 23 (6) | 13 (13) |
| High fat foods | 16 (4) | 5 (5) |
| Cereals/grains | 12 (3) | 10 (10) |
| Fruit | 1 (0.3) | 13 (13) |
| Meat | 10 (3) | 7 (7) |
| Eggs | 5 (1) | 7 (7) |
| Pizza | 5 (1) | 1 (1) |
Factors influencing symptoms
Differences between males and females
Differences in experiences of digestive symptoms or the perceptions of the impact of foods/drinks were identified between males and females For participants without any GI conditions, a significantly greater proportion of females (85.7%) reported symptoms compared to males (61.9%) (P < 0.01), stated that foods or drinks induce symptoms (females: 72.7% vs. males: 60.3%) (P < 0.05) and stated that they would avoid certain foods or drinks because they induce symptoms (females: 44.8% vs. males: 27.0%) (P < 0.05). Women also had higher total symptom scores compared to men (females: median (IQR) 21 (27) vs. males: 6 (19) (P < 0.01).
Personality traits
The TIPI and obsessional behaviour scores of the participants are shown in Table 4.
Table 4.
Median and Mean TIPI scores and mean obsessional behaviour scores of participants (n = 472)
| TIPI scores | Mean | SD |
|---|---|---|
| Extraversion | 8.0 | 3.2 |
| Emotional Stability | 8.5 | 2.9 |
| Openness to experiences | 9.8 | 2.2 |
| Median | IQR | |
| Agreeableness | 11.0 | 3.0 |
| Conscientiousness | 11.0 | 3.0 |
| Mean | SD | |
| Obsessional behaviour score | 27.0 | 9.3 |
In those with no GI conditions, there was no relationship between the symptom score and extraversion, agreeableness, conscientiousness or openness to experience but there was a negative correlation with emotional stability (r = − 0.221; p < 0.01). The symptom score was also weakly positively correlated with the obsessional behaviour score (r = 0.108;p < 0.05). There were no correlations between any personality traits and symptom scores in those with IBS.
Physical activity
Overall, 28% of participants had a high activity IPAQ score, 51% had medium and 21% had low activity scores. There were no significant differences in symptom scores by IPAQ scores in either healthy or IBS groups.
Medication use and symptoms
Respondents without established GI conditions but who took anti-reflux/antacid medication had a higher symptom score than those who did not (P < 0.001) (Table 5). More also reported symptoms when they consume certain foods/drinks and avoid certain foods/drinks because of this (P < 0.01).
Table 5.
Differences between respondents without any GI conditions who take anti-reflux/antacid medication
| Do not take anti-reflux medication (n = 273) | Take anti-reflux medication (n = 99) | P | |
|---|---|---|---|
| Total symptom score**1 | 16 (28) | 28 (37) | < 0.001 |
| Foods/drinks induce symptoms*2 | 182 (66.7) | 81 (81.8) | < 0.01 |
| Avoids foods/drinks because they induce symptoms*2 | 105 (38.5) | 51 (51.5) | < 0.01 |
*n (%), ** median (IQR). 1Analysed using Mann Whitney U Test, 2Analysed using Chi squared Test
A greater proportion of those who take anti-reflux/antacid medication experienced all GI symptoms compared to those who do not take medication, however, this was most notable with the upper GI symptoms belching (no medication: 31.5% vs. anti-reflux medication: 49.5%) and heartburn (no medication: 26.7% vs. anti-reflux medication: 80.8%) (P < 0.01).
Fruit, vegetable and fibre consumption
Overall, around half of the participants (49.5% no GI conditions; 52% IBS) thought they ate 5 or more portions of fruit and vegetables per day. In both groups, these participants had significantly lower symptom scores than for those who ate less than 5 a day (20.9 vs. 25.8 Healthy; 41.4 vs. 54.1 IBS, p < 0.05). There was also a negative correlation between fibre intake and symptoms scores in both groups (r = − 0.143; p < 0.05 Healthy; r = − 0.223; p < 0.05 IBS).
Discussion
Reports of GI symptoms were common in this respondent sample, and for many, symptoms negatively impact their lives despite being mild. Although reports of symptoms in our study were higher than has previously been reported, others have found a similar impact of mild symptoms on quality of life in healthy individuals [23–25, 46, 47]. The higher reporting of symptoms in our study compared to past research may be explained in part by the fact our sample was self-selected, therefore, those who chose to participate may have been more aware of their own symptoms than the general population. A higher proportion of our sample reported consuming > 5 portions of fruit and vegetables per day (49.6%) compared to the UK national average (33%) which may also have influenced results [5]. However, this could also be due to differences in cultural norms, customs, beliefs and language between UK adults and other study populations. For example, language differences may mean that interpretation of symptoms differs between countries [48].
Many survey respondents felt that diet was a factor in causing their symptoms (76%) and reported that this may impact their decision to consume certain foods. Previous research into dietary causes of GI symptoms has been predominantly conducted in individuals with IBS, where up to 84% of respondents report symptoms related to foods [44]. Lower GI symptoms were more commonly reported as being caused by foods/drinks in our survey and elicited more concern than upper GI symptoms which is in agreement with previous work in healthy adults [49] and in those with IBS [45, 50, 51]. Foods high in fermentable carbohydrate (beans, Brussels sprouts, cabbage, lentils) were commonly reported as causing flatulence by respondents which was not surprising considering the longstanding perceptions that these foods cause gaseous symptoms [52]. However, those claiming higher fibre and fruit and vegetable intakes in this study had lower symptoms scores than those who ate less. Dairy foods/drinks and fatty foods were more commonly reported as causing abdominal bloating, pain and rumbling compared to plant foods high in fermentable carbohydrates. Reduced activity or expression of lactase may result in the malabsorption of lactose and subsequent digestive symptoms [53]. Lactase activity reduces as we age but varies depending on ethnic group/geographic location [54].
The role of fat in digestive symptoms has been attributed to several mechanisms, which are not fully understood, relating to the sensitisation of gastric perceptions, cholecystokinin release, and intestinal gas accumulation [55]. In individuals who experience bloating following fat consumption, duodenal lipids have been shown to inhibit small bowel motility and impair intestinal gas clearance leading to increased gas retention and bloating [56]. Duodenal lipids have also been shown to increase colorectal sensitivity particularly in individuals with IBS [57].
Spicy foods were also reported to cause several digestive symptoms, diarrhoea, more so than any other food/drink, there were also many reports of heartburn, flatulence and abdominal pain and bloating. The presence of capsaicin in spicy foods can activate TRPV1 receptors in the GI tract causing heartburn and accelerating intestinal transit inducing abdominal pain, loosening bowel movements and increasing the rate of delivery of fermentable substrates to the colon [58, 59].
The belief or expectation that certain foods may induce GI symptoms can influence symptomatic experience [52, 60]. This was demonstrated in a study looking at perceptions of flatulence following bean consumption, where in many cases the anticipation of symptoms was greater than reported symptoms [52]. The potential influence of preconceptions on experience was also observed in a blinded study looking at the impact of a non-absorbable fat substitute (olestra) on GI symptoms [60]. The authors found that after informing all participants of potential GI symptoms they may experience after consuming the fat substitute, very similar proportions of the control (36.9%) and olestra (38.2%) groups reported symptoms. The negative impact of this situation may be the avoidance of foods that may not induce symptoms to the extent individuals perceive. This potentially modifiable barrier to consumption is important to address considering the suboptimal dietary habits of many countries [61, 62].
Although the study was not designed to assess differences between males and females and was therefore not balanced, we found that female respondents were more likely to report symptoms and have negative perceptions of symptoms and food compared to men. This is in agreement with previous findings in irritable bowel syndrome [63–65]. The reasons for this are not clear but could be related to increased symptom reporting in females, increased prevalence of mood or affective disorders and menstrual cycle-related changes in gastrointestinal function and visceral sensitivity [63–65].
We also found that those who take anti-reflux medication experience more symptoms and food-related symptoms compared to those who do not. This study was not designed to assess these differences, however, a considerable proportion of the respondents were taking anti-reflux medication, therefore, it was important to explore the possible impact of this. We did not differentiate between medications so can only speculate as to the potential role of any medication in these symptoms. Perhaps these individuals were more likely to report symptoms and receive medication as a result. It is also well established that some of these medications, proton pump inhibitors particularly, are associated with both short and long term adverse gastrointestinal effects including abdominal pain, flatulence, nausea and diarrhoea [66, 67].
The participants in our study were self-selected, and those who chose to participate may have been more aware of their own symptoms than the general population. However, in general the symptom scores were low for most participants. Another potential limitation is the representativeness of the study respondents. Seventy seven percent of respondents had a university degree (undergraduate: 37%, postgraduate: 40%) which is considerably greater than the UK general population (26–34%) [68, 69]. Also, by advertising and conducting the survey only online, we may have excluded a portion of the population without access to the internet or a device to complete the survey on.
Conclusion
GI symptoms and perceptions of dietary causes of symptoms were common in this study. Despite flatulence being the most commonly reported symptom, only a very small proportion of respondents were worried by it. Therefore, the perception that foods rich in fermentable fibres (beans, Brussels sprouts and lentils) might cause flatulence, may not be a considerable barrier to increased fibre intake. However, this does demonstrate that some individuals may benefit from reassurance alongside dietary advice that with sustained increased fibre intake symptoms may lessen over time. It is also important to highlight that fibre-rich foods were not most commonly associated with symptoms perceived as being the most concerning (abdominal pain, bloating and heartburn); instead these were associated with fatty, dairy and spicy foods. Creating better public understanding of the relatively low concern expressed of gut symptoms associated with higher fibre foods by individuals and the lower frequency of symptoms in those eating more fibre and fruit and vegetables may help in addressing barriers to increasing fibre consumption.
Funding
C. L. T. was a PhD student funded by the UKRI-BBSRC CTP programme in partnership with Mondelez International (BBSRC grant award number: 2294514).
References
- 1.The Scottish Government. A Healthier Future – Scotland’s Diet & Healthy Weight Delivery Plan. 2018.
- 2.The Scottish Government. Revised Dietary Goals for Scotland 2016:1–7.
- 3.National Health Service. A Quick Guide to the Government’s Healthy Eating Recommendations. Public Heal Engl 2018.
- 4.Rowland M, Rose J, McLean J, Knudsen L, Poliakov I, Foster E et al (2020) Pilot of intake24 in the scottish health survey. Scotland: ScotCen Social Res. 2020:155 [Google Scholar]
- 5.Public Health England. National Diet and Nutrition Survey. Rolling programme Years 9 to 11 (2016/2017 to 2018/2019) 2020, 11, pp. 1–29.
- 6.Lockyer S, Spiro A, Stanner S (2016) Dietary fibre and the prevention of chronic disease—should health professionals be doing more to raise awareness? Nutr Bull 41:214–231. 10.1111/nbu.12212 [Google Scholar]
- 7.Henn K, Goddyn H, Olsen SB, Bredie WLP (2022) Identifying behavioral and attitudinal barriers and drivers to promote consumption of pulses: a quantitative survey across five European countries. Food Qual Prefer 98:104455. 10.1016/j.foodqual.2021.104455 [Google Scholar]
- 8.Grabitske HA, Slavin JL (2009) Gastrointestinal effects of low-digestible carbohydrates. Crit Rev Food Sci Nutr 49:327–360. 10.1080/10408390802067126 [DOI] [PubMed] [Google Scholar]
- 9.Misselwitz B, Butter M, Verbeke K, Fox MR (2019) Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management. Gut 68:2080–2091. 10.1136/gutjnl-2019-318404 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Lenhart A, Chey WD (2017) A systematic review of the effects of polyols on gastrointestinal health and irritable bowel syndrome. Adv Nutr 8:587–596. 10.3945/an.117.015560 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hasler WL (2006) Gas and bloating. Gastroenterol Hepatol (N Y) 2:654–662 [PMC free article] [PubMed] [Google Scholar]
- 12.Colomier E, Melchior C, Algera JP, Hreinsson JP, Störsrud S, Törnblom H et al (2022) Global prevalence and burden of meal-related abdominal pain. BMC Med 20:71. 10.1186/s12916-022-02259-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Marteau P, Flourié B (2001) Tolerance to low-digestible carbohydrates: symptomatology and methods. Br J Nutr 85:S17-21. 10.1079/BJN2000258 [DOI] [PubMed] [Google Scholar]
- 14.Lee AD, Spiegel BM, Hays RD, Melmed GY, Bolus R, Khanna D et al (2017) Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population. Neurogastroenterol Motil 29:e13003. 10.1111/nmo.13003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Azpiroz F, Guyonnet D, Donazzolo Y, Gendre D, Tanguy J, Guarner F (2015) Digestive symptoms in healthy people and subjects with irritable bowel syndrome. J Clin Gastroenterol 49:e64-70. 10.1097/MCG.0000000000000178 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Lasser RB, Bond JH, Levitt MD (1975) The role of intestinal gas in functional abdominal pain. N Engl J Med 293:524–526. 10.1056/NEJM197509112931103 [DOI] [PubMed] [Google Scholar]
- 17.King T, Elia M, Hunter J (1998) Abnormal colonic fermentation in irritable bowel syndrome. Lancet 352:1187–1189. 10.1016/S0140-6736(98)02146-1 [DOI] [PubMed] [Google Scholar]
- 18.Haderstorfer B, Psycholgin D, Whitehead WE, Schuster MM (1989) Intestinal gas production from bacterial fermentation of undigested carbohydrate in irritable bowel syndrome. Am J Gastroenterol 84:375–378 [PubMed] [Google Scholar]
- 19.Maxton DG, Martin DF, Whorwell PJ, Godfrey M (1991) Abdominal distension in female patients with irritable bowel syndrome: exploration of possible mechanisms. Gut 32:662–664. 10.1136/gut.32.6.662 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Serra J (2001) Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut 48:14–19. 10.1136/gut.48.1.14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Enck P, Aziz Q, Barbara G, Farmer AD, Fukudo S, Mayer EA et al (2016) Irritable bowel syndrome. Nat Rev Dis Prim 2:16014. 10.1038/nrdp.2016.14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Quigley EMM, Locke GR, Mueller-Lissner S, Paulo LG, Tytgat GN, Helfrich I et al (2006) Prevalence and management of abdominal cramping and pain: a multinational survey. Aliment Pharmacol Ther 24:411–419. 10.1111/j.1365-2036.2006.02989.x [DOI] [PubMed] [Google Scholar]
- 23.van Kerkhoven LAS, Eikendal T, Laheij RJF, van Oijen MGH, Jansen JBMJ (2008) Gastrointestinal symptoms are still common in a general Western population. Neth J Med 66:18–22 [PubMed] [Google Scholar]
- 24.Almario CV, Ballal ML, Chey WD, Nordstrom C, Khanna D, Spiegel BMR (2018) Burden of gastrointestinal symptoms in the United States: results of a nationally representative survey of over 71,000 Americans. Am J Gastroenterol 113:1701–1710. 10.1038/s41395-018-0256-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.L’Heureux-Bouron D, Legrain-Raspaud S, Carruthers HR, Whorwell PJ (2018) Minor digestive symptoms and their impact in the general population: a cluster analysis approach. Therap Adv Gastroenterol 11:175628481876881. 10.1177/1756284818768814 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Nicholas JK, Tilburg MAL, Pilato I, Erwin S, Rivera-Cancel AM, Ives L et al (2021) The diagnosis of avoidant restrictive food intake disorder in the presence of gastrointestinal disorders: opportunities to define shared mechanisms of symptom expression. Int J Eat Disord 54:995–1008. 10.1002/eat.23536 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Melchior C, Algera J, Colomier E, Törnblom H, Simrén M, Störsrud S (2022) Food avoidance and restriction in irritable bowel syndrome: relevance for symptoms, quality of life and nutrient intake. Clin Gastroenterol Hepatol 20:1290-1298.e4. 10.1016/j.cgh.2021.07.004 [DOI] [PubMed] [Google Scholar]
- 28.Bek S, Teo YN, Tan X, Fan KHR, Siah KTH (2022) Association between irritable bowel syndrome and micronutrients: a systematic review. J Gastroenterol Hepatol 37:1485–1497. 10.1111/jgh.15891 [DOI] [PubMed] [Google Scholar]
- 29.Lenhart A, Dong T, Joshi S, Jaffe N, Choo C, Liu C et al (2022) Effect of exclusion diets on symptom severity and the gut microbiota in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 20:e465–e483. 10.1016/j.cgh.2021.05.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Hayes P, Corish C, O’Mahony E, Quigley EMM (2014) A dietary survey of patients with irritable bowel syndrome. J Hum Nutr Diet 27:36–47. 10.1111/jhn.12114 [DOI] [PubMed] [Google Scholar]
- 31.Cochran, W. Sampling Techniques 1977. 3rd edn. John Wiley & Sons, Inc. Available at: http://www.ru.ac.bd/stat/wpcontent/uploads/sites/25/2019/03/407_03_Cochran_Sampling_Techniques_3rd-ed.pdf.
- 32.Office for National Statistics. Estimates of the population for the UK, England, Wales, Scotland and Northern Ireland 2022. Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/populationestimatesforukenglandandwalesscotlandandnorthernireland.
- 33.Bartlett JE, Kotrlik JW, Higgins CC (2001) Organizational research: determining appropriate sample size in survey research. Inf Technol Learn Perform J 19(1):43–50 [Google Scholar]
- 34.Bovenschen HJ, Janssen MJR, van Oijen MGH, Laheij RJF, van Rossum LGM, Jansen JBMJ (2006) Evaluation of a gastrointestinal symptoms questionnaire. Dig Dis Sci 51:1509–1515. 10.1007/s10620-006-9120-6 [DOI] [PubMed] [Google Scholar]
- 35.Gagné J-P, Van Kirk N, Hernandez-Vallant A, Potluri S, Krompinger JW, Cattie JE et al (2018) Validating an abbreviated version of the obsessive beliefs questionnaire. J Clin Psychol 74:1791–1807. 10.1002/jclp.22629 [DOI] [PubMed] [Google Scholar]
- 36.Gosling SD, Rentfrow PJ, Swann WB (2003) A very brief measure of the big-five personality domains. J Res Pers 37:504–528. 10.1016/S0092-6566(03)00046-1 [Google Scholar]
- 37.Labus JS, Bolus R, Chang L, Wiklund I, Naesdal J, Mayer EA et al (2004) The visceral sensitivity index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther 20:89–97. 10.1111/j.1365-2036.2004.02007.x [DOI] [PubMed] [Google Scholar]
- 38.Lee PH, Macfarlane DJ, Lam T, Stewart SM (2011) Validity of the international physical activity questionnaire short form (IPAQ-SF): a systematic review. Int J Behav Nutr Phys Act 8:115. 10.1186/1479-5868-8-115 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Lewis SJ, Heaton KW (1997) Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 32:920–924. 10.3109/00365529709011203 [DOI] [PubMed] [Google Scholar]
- 40.Ortega F, Bravo J, Cantarell C, Cofán F, Gómez-Bravo MA, Miras M et al (2012) Development and validation of a specific questionnaire for evaluating the impact of gastrointestinal symptoms on the health-related quality of life of transplant patients. Transplant Proc 44:1281–1286. 10.1016/j.transproceed.2012.01.114 [DOI] [PubMed] [Google Scholar]
- 41.Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sport Exerc 35:1381–1395. 10.1249/01.MSS.0000078924.61453.FB [DOI] [PubMed] [Google Scholar]
- 42.Fergus TA, Latendresse SJ, Wu KD (2017) Factor structure and further validation of the 20-item short form of the obsessive beliefs questionnaire. Assessment 26(6):984–1000 [DOI] [PubMed] [Google Scholar]
- 43.Bender AE, Matthews DR (1981) Adverse reactions to foods. Br J Nutr 46:403–407. 10.1079/BJN19810048 [DOI] [PubMed] [Google Scholar]
- 44.Böhn L, Störsrud S, Törnblom H, Bengtsson U, Simrén M (2013) Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol 108:634–641. 10.1038/ajg.2013.105 [DOI] [PubMed] [Google Scholar]
- 45.Simrén M, Månsson A, Langkilde AM, Svedlund J, Abrahamsson H, Bengtsson U et al (2001) Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 63:108–115. 10.1159/000051878 [DOI] [PubMed] [Google Scholar]
- 46.Tielemans MM, Jaspers Focks J, van Rossum LGM, Eikendal T, Jansen JBMJ, Laheij RJF et al (2013) Gastrointestinal symptoms are still prevalent and negatively impact health-related quality of life: a large cross-sectional population based study in the Netherlands. PLoS ONE 8:e69876. 10.1371/journal.pone.0069876 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Avramidou M, Angst F, Angst J, Aeschlimann A, Rössler W, Schnyder U (2018) Epidemiology of gastrointestinal symptoms in young and middle-aged Swiss adults: prevalences and comorbidities in a longitudinal population cohort over 28 years. BMC Gastroenterol 18:21. 10.1186/s12876-018-0749-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Francisconi CF, Sperber AD, Fang X, Fukudo S, Gerson M-J, Kang J-Y et al (2016) Multicultural aspects in functional gastrointestinal disorders (FGIDs). Gastroenterology 150:1344-1354.e2. 10.1053/j.gastro.2016.02.013 [DOI] [PubMed] [Google Scholar]
- 49.Burr ML, Merrett TG (1983) Food intolerance: a community survey. Br J Nutr 49:217–219. 10.1079/BJN19830028 [DOI] [PubMed] [Google Scholar]
- 50.Jansson-Knodell CL, White M, Lockett C, Xu H, Shin A (2022) Associations of food intolerance with irritable bowel syndrome, psychological symptoms, and quality of life. Clin Gastroenterol Hepatol 20:2121-2131.e3. 10.1016/j.cgh.2021.12.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Bouchoucha M, Devroede G, Raynaud J-J, Bon C, Bejou B, Benamouzig R (2011) Is the colonic response to food different in IBS in contrast to simple constipation or diarrhea without abdominal pain? Dig Dis Sci 56:2947–2956. 10.1007/s10620-011-1700-4 [DOI] [PubMed] [Google Scholar]
- 52.Winham DM, Hutchins AM (2011) Perceptions of flatulence from bean consumption among adults in 3 feeding studies. Nutr J 10:128. 10.1186/1475-2891-10-128 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Szilagyi A, Ishayek N (2018) Lactose intolerance, dairy avoidance, and treatment options. Nutrients 10:1994. 10.3390/nu10121994 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Fassio F, Facioni M, Guagnini F (2018) Lactose maldigestion, malabsorption, and intolerance: a comprehensive review with a focus on current management and future perspectives. Nutrients 10:1599. 10.3390/nu10111599 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Fried M, Feinle C (2002) The role of fat and cholecystokinin in functional dyspepsia. Gut 51:i54–i57. 10.1136/gut.51.suppl_1.i54 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Hernando-Harder AC (2004) Sites of symptomatic gas retention during intestinal lipid perfusion in healthy subjects. Gut 53:661–665. 10.1136/gut.2003.026385 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Simrén M, Agerforz P, Björnsson ES, Abrahamsson H (2007) Nutrient-dependent enhancement of rectal sensitivity in irritable bowel syndrome (IBS). Neurogastroenterol Motil 19:20–29. 10.1111/j.1365-2982.2006.00849.x [DOI] [PubMed] [Google Scholar]
- 58.Gonlachanvit S (2010) Are rice and spicy diet good for functional gastrointestinal disorders? J Neurogastroenterol Motil 16:131–138. 10.5056/jnm.2010.16.2.131 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816–824. 10.1038/39807 [DOI] [PubMed] [Google Scholar]
- 60.Sandler RS (1999) Gastrointestinal symptoms in 3181 volunteers ingesting snack foods containing Olestra or triglycerides for 6 weeks. Ann Intern Med 130:253. 10.7326/0003-4819-130-4_Part_1-199902160-00002 [DOI] [PubMed] [Google Scholar]
- 61.Public Health England. National Diet and Nutrition Survey. Rolling programme Years 9 to 11 (2016/2017 to 2018/2019) 2020;11:1–29.
- 62.The Scottish Government (2020) Diet and healthy weight: monitoring report. GovScot 2020:1–28 [Google Scholar]
- 63.Fan W, Chen Y, Fang X, Zhu L, Fei G, Lu J et al (2024) Gender differences in gastrointestinal, biopsychosocial and healthcare-seeking behaviors in Chinese patients with irritable bowel syndrome predominant with diarrhea. BMC Gastroenterol 24(1):102 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Cain KC, Jarrett ME, Burr RL, Rosen S, Hertig VL, Heitkemper MM (2009) Gender differences in gastrointestinal, psychological, and somatic symptoms in irritable bowel syndrome. Dig Dis Sci [Internet]. 54(7):1542–1549. 10.1007/s10620-008-0516-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Meleine M (2014) Gender-related differences in irritable bowel syndrome: Potential mechanisms of sex hormones. World J Gastroenterol [Internet]. 20(22):6725s [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Vakil NB, Shaker R, Johnson DA, Kovacs T, Baerg RD, Hwang C et al (2001) The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety. Aliment Pharmacol Ther [Internet]. 15(7):927–935. 10.1046/j.1365-2036.2001.01024.x [DOI] [PubMed] [Google Scholar]
- 67.Vaezi MF, Yang YX, Howden CW (2017) Complications of proton pump inhibitor therapy. Gastroenterology [Internet]. 153(1):35–48ss [DOI] [PubMed] [Google Scholar]
- 68.Waddington B. Education, England and Wales: Census 2021. 2021.
- 69.National Records of Scotland. Scotland’s census 2011. 2011.


